© 2021 MJH Life Sciences and Psychiatric Times. All rights reserved.
© 2021 MJH Life Sciences™ and Psychiatric Times. All rights reserved.
February 16, 2021
Research on the prevalence of ADHD in Black individuals in the United States highlights the need for future research in this underrepresented group.
February 08, 2021
Is it possible to use cognitive testing, which is brief, easily performed, reliable, and noninvasive, to identify individuals at risk for psychosis?
February 04, 2021
Researchers explored reactivity to a panel of EBV proteins in patients with schizophrenia, thought to be associated with cognitive impairment.
How do men versus women with schizophrenia fare clinically, functionally, and neuropsychologically over the long term?
February 02, 2021
Are there differences in the clinical course of bipolar I and bipolar II disorder with and without comorbid alcohol use disorder?
January 21, 2021
Schizophrenia is associated with cognitive impairment, and treatment of cognitive dysfunction in these patients represents an area of unmet need. What is the role of exercise?
January 06, 2021
December 14, 2020
Navigating the treatment options for comorbid schizophrenia and alcohol use
November 19, 2020
Recent research sheds light on the role of adjunctive long-acting injectable antipsychotics in treatment-resistant schizophrenia.
November 06, 2020
Data from a randomized phase III trial shows promise for new treatment strategy.